@article {326,
	title = {A new platform for ultra-high dose rate radiobiological research using the BELLA PW laser proton beamline.},
	journal = {Sci Rep},
	volume = {12},
	year = {2022},
	month = {2022 01 27},
	pages = {1484},
	abstract = {<p>Radiotherapy is the current standard of care for more than 50\% of all cancer patients. Improvements in radiotherapy (RT) technology have increased tumor targeting and normal tissue sparing. Radiations at ultra-high dose rates required for FLASH-RT effects have sparked interest in potentially providing additional differential therapeutic benefits. We present a new experimental platform that is the first one to deliver petawatt laser-driven proton pulses of 2\&nbsp;MeV energy at 0.2\&nbsp;Hz repetition rate by means of a compact, tunable active plasma lens beamline to biological samples. Cell monolayers grown over a 10\&nbsp;mm diameter field were exposed to clinically relevant proton doses ranging from 7 to 35\&nbsp;Gy at ultra-high instantaneous dose rates of 10\&nbsp;Gy/s. Dose-dependent cell survival measurements of human normal and tumor cells exposed to LD protons showed significantly higher cell survival of normal-cells compared to tumor-cells for total doses of 7\&nbsp;Gy and higher, which was not observed to the same extent for X-ray reference irradiations at clinical dose rates. These findings provide preliminary evidence that compact LD proton sources enable a new and promising platform for investigating the physical, chemical and biological mechanisms underlying the FLASH effect.</p>
},
	keywords = {Cell Line, Humans, Lasers, Monte Carlo Method, Neoplasms, Proton Therapy, Radiation Oncology, Radiobiology, Radiometry, Radiotherapy Dosage, Synchrotrons},
	issn = {2045-2322},
	doi = {10.1038/s41598-022-05181-3},
	author = {Bin, Jianhui and Obst-Huebl, Lieselotte and Mao, Jian-Hua and Nakamura, Kei and Geulig, Laura D and Chang, Hang and Ji, Qing and He, Li and De Chant, Jared and Kober, Zachary and Gonsalves, Anthony J and Bulanov, Stepan and Celniker, Susan E and Schroeder, Carl B and Geddes, Cameron G R and Esarey, Eric and Simmons, Blake A and Schenkel, Thomas and Blakely, Eleanor A and Steinke, Sven and Snijders, Antoine M}
}
@article {86,
	title = {Linking changes in epithelial morphogenesis to cancer mutations using computational modeling},
	journal = {PLoS Comput Biol},
	volume = {6},
	year = {2010},
	month = {2010},
	abstract = {<p>Most tumors arise from epithelial tissues, such as mammary glands and lobules, and their initiation is associated with the disruption of a finely defined epithelial architecture. Progression from intraductal to invasive tumors is related to genetic mutations that occur at a subcellular level but manifest themselves as functional and morphological changes at the cellular and tissue scales, respectively. Elevated proliferation and loss of epithelial polarization are the two most noticeable changes in cell phenotypes during this process. As a result, many three-dimensional cultures of tumorigenic clones show highly aberrant morphologies when compared to regular epithelial monolayers enclosing the hollow lumen (acini). In order to shed light on phenotypic changes associated with tumor cells, we applied the bio-mechanical IBCell model of normal epithelial morphogenesis quantitatively matched to data acquired from the non-tumorigenic human mammary cell line, MCF10A. We then used a high-throughput simulation study to reveal how modifications in model parameters influence changes in the simulated architecture. Three parameters have been considered in our study, which define cell sensitivity to proliferative, apoptotic and cell-ECM adhesive cues. By mapping experimental morphologies of four MCF10A-derived cell lines carrying different oncogenic mutations onto the model parameter space, we identified changes in cellular processes potentially underlying structural modifications of these mutants. As a case study, we focused on MCF10A cells expressing an oncogenic mutant HER2-YVMA to quantitatively assess changes in cell doubling time, cell apoptotic rate, and cell sensitivity to ECM accumulation when compared to the parental non-tumorigenic cell line. By mapping in vitro mutant morphologies onto in silico ones we have generated a means of linking the morphological and molecular scales via computational modeling. Thus, IBCell in combination with 3D acini cultures can form a computational/experimental platform for suggesting the relationship between the histopathology of neoplastic lesions and their underlying molecular defects.</p>},
	keywords = {Apoptosis, Biological, Breast Neoplasms, Cell Proliferation, Computer Simulation, Epithelium, ErbB-2, Extracellular Matrix, Female, Human, Humans, Mammary Glands, Models, Morphogenesis, Mutation, Receptor},
	issn = {1553-7358},
	doi = {10.1371/journal.pcbi.1000900},
	author = {Rejniak, Katarzyna A and Wang, Shizhen E and Bryce, Nicole S and Hang Chang and Parvin, Bahram and Jourquin, Jerome and Estrada, Lourdes and Gray, Joe W and Arteaga, Carlos L and Weaver, Alissa M and Quaranta, Vito and Anderson, Alexander R A}
}
